Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium

被引：0
|
作者：
Newton, Meredith [1 ]
Burkett, Wesley [1 ]
Zhao, Ziyi [1 ]
Secord, Angeles Alvarez [2 ,3 ]
Zhou, Chunxiao [1 ]
Bae-Jump, Victoria [1 ]
机构：
[1] Univ N Carolina, Durham, NC USA
[2] Duke Canc Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
045
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 17 条
  • [1] Ipatasertib, an oral AKT inhibitor, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    O'Donnell, Jillian
    Buckingham, Lindsey
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S41 - S42
  • [2] Ipatasertib, an oral AKT inhibitor, in combination with paclitaxel exhibits anti-proliferative and anti-tumorigenic effects in preclinical studies for endometrioid endometrial cancer: Endometrial cancer molecularly targeted therapy consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S125 - S126
  • [3] Ipatasertib, an oral AKT inhibitor, in combination with carboplatin exhibits anti-proliferative effects in serous endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Burkett, Wesley
    Newton, Meredith
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S130 - S131
  • [4] Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer
    John, Catherine
    Shen, Xiaochang
    Deng, Boer
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    Secord, Angeles Alvarez
    Batinic-Haberle, Ines
    Spasojevic, Ivan
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S37 - S38
  • [5] Onvansertib exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer
    Sinha, Nikita
    Shen, Xiaochang
    Haag, Jennifer
    Chen, Shuning
    Emanuele, Michael
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S457 - S458
  • [6] Oleic acid, a monounsaturated fatty acid, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer
    Newton, Meredith
    Suo, Hongyan
    Burkett, Wesley
    Zhao, Ziyi
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S140 - S140
  • [7] Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in endometrioid and serous endometrial cancer cell lines in vitro (Endometrial Cancer Molecularly Targeted Therapy Consortium)
    Buckingham, Lindsey
    O'Donnell, Jillian
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 387 - 388
  • [8] Ipatasertib exhibits anti-tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo
    O'donnell, Jillian
    Zhao, Ziyi
    Buckingham, Lindsey
    Hao, Tianran
    Suo, Hongyan
    Zhang, Xin
    Fan, Yali
    John, Catherine
    Deng, Boer
    Shen, Xiaochang
    Sun, Wenchuan
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria L. L.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (03)
  • [9] Ipatasertib, an oral AKT inhibitor, effectively inhibits cell proliferation and migration, and induces apoptosis in serous endometrial cancer cell lines in vitro: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Buckingham, Lindsey
    O'Donnell, Jillian
    Hao, Tianran
    Alvarez-Secord, Angeles
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S192 - S193
  • [10] SPR 064, a highly soluble taxane, exhibits anti-tumorigenic effects in endometrial cancer
    Staley, A.
    Tucker, K.
    Fan, Y.
    Zhao, X.
    Yin, Y.
    Fang, Z.
    Sun, W.
    Sen, S.
    Dugar, S.
    Zhang, Y.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 48 - 48
12